Clinical Trial to Investigate the Pharmacokinetics of Second-Line Anti-Tuberculosis Agents
Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
This study aims to investigate the pharmacokinetic characteristics of second-line
anti-tuberculosis agents after oral/intramuscular administration in healthy male volunteers.